Protocol design does not struggle in the protocol. It struggles in the transition to trial, when assumptions embedded in the ...
FDA proof-of-concept trials with AstraZeneca and Amgen validate continuous data transmission and signal detection, setting ...
This causes frustration for all stakeholders – sponsors, CROs, and eCOA providers alike. Yet, many of these challenges are ...
Simulations of a real-world explanatory trial of transarterial radioembolization for advanced unresectable hepatocellular carcinoma with portal vein invasion were performed to examine the effects of ...
How AI Is Transforming Trial Design Artificial intelligence has become an integral part of the vision for clinical research ...
Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...
BRANFORD, Conn.--(BUSINESS WIRE)--Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced ...
A common thread in your work has been connecting people to clinical trials. Was that the focus in founding the CARE Research Center? The impetus behind the CARE Research Center is probably not so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results